VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Turn Therapeutics Inc. (TTRX) Total Return Calculator with Dividends Reinvested

Turn Therapeutics Inc.

Popular:

The total return for Turn Therapeutics Inc. (TTRX) stock is -45.86% over the past 12 months. So far it's down 19.19% this year. The 5-year total return is -45.86%, meaning $10,000 invested in TTRX stock 5 years ago would be worth $5,414 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in TTRX 1 year ago, it would be worth $5,414 today — you'd have lost $4,586.

With Dividends Reinvested$5,414-45.86%

Price Only (No DRIP)$5,414-45.86%

Period2025-10-08 → 2026-05-08

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in TTRX

1Y$5,414-$4,586 (-45.9%)-45.9% CAGR

3Y$5,414-$4,586 (-45.9%)-18.5% CAGR

5Y$5,414-$4,586 (-45.9%)-11.5% CAGR

10Y$5,414-$4,586 (-45.9%)-6.0% CAGR

15Y$5,414-$4,586 (-45.9%)-4.0% CAGR

20Y$5,414-$4,586 (-45.9%)-3.0% CAGR

30Y$5,414-$4,586 (-45.9%)-2.0% CAGR

Turn Therapeutics Inc. did not pay dividends during this period. Total return = price return.

Loading TTRX total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-19.19%	—	-19.19%	—	$8,081
1Y	-45.86%	-45.86%	-45.86%	—	$5,414
3Y	-45.86%	-18.50%	-45.86%	—	$5,414
5Y	-45.86%	-11.55%	-45.86%	—	$5,414
10Y	-45.86%	-5.95%	-45.86%	—	$5,414
15Y	-45.86%	-4.01%	-45.86%	—	$5,414
20Y	-45.86%	-3.02%	-45.86%	—	$5,414
30Y	-45.86%	-2.02%	-45.86%	—	$5,414

Risk & Highlights

Best Year-43.71%2025

Max Drawdown-70.54%2025-10-09 → 2025-11-20

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-23.24%	-23.24%	—	+0.41%	-23.7pp
2025	-43.71%	-43.71%	—	+16.64%	-60.4pp

TTRX underperformed the S&P 500 by 76.40pp over the past year (-45.86% vs +30.54%).

Loading summary...

TTRX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
TTRXTurn Therapeutics Inc.	$112M	+8.3%	-19.2%	-45.9%	—	-45.9%	-45.9%	-45.9%
RCUSArcus Biosciences, Inc.	$2.6B	+12.0%	+8.9%	+197.3%	—	+27.8%	-12.1%	+49.2%
IMVTImmunovant, Inc.	$5.9B	+17.0%	+11.7%	+102.4%	—	+49.8%	+84.4%	+190.9%
ARQTArcutis Biotherapeutics, Inc.	$2.6B	-14.0%	-27.0%	+56.6%	—	+48.5%	-35.0%	-2.9%
KYMRKymera Therapeutics, Inc.	$7.0B	-1.2%	+18.3%	+179.8%	—	+210.3%	+95.8%	+158.8%
PRAXPraxis Precision Medicines, Inc.	$9.5B	+3.1%	+15.2%	+767.1%	—	+1956.2%	-14.9%	-20.9%
RVMDRevolution Medicines, Inc.	$30.1B	+46.6%	+79.5%	+238.4%	—	+480.2%	+375.9%	+390.7%
VRTXVertex Pharmaceuticals Incorporated	$109.3B	-3.2%	-4.9%	+0.1%	—	+24.9%	+101.9%	+388.1%
REGNRegeneron Pharmaceuticals, Inc.	$74.3B	-7.8%	-7.8%	+31.2%	+0.7pp	-4.4%	+43.2%	+91.6%
ABBVAbbVie Inc.	$356.5B	-4.9%	-10.6%	+12.2%	+3.6pp	+49.7%	+99.6%	+293.8%
INVAInnoviva, Inc.	$1.9B	-3.1%	+15.2%	+23.2%	—	+96.0%	+94.5%	+95.6%

Compare:TTRX vs RCUS TTRX vs IMVT TTRX vs ARQT TTRX vs RCUS vs IMVT

About TTRX Dividend Returns

Turn Therapeutics Inc. (TTRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of TTRX over the past year?

Turn Therapeutics Inc. (TTRX) delivered a return of -45.86% over the past year. Since TTRX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in TTRX be worth today?

A $10,000 investment in Turn Therapeutics Inc. one year ago would be worth $5,414 today, representing a loss of $4,586.

Q3Does TTRX pay dividends?

Turn Therapeutics Inc. (TTRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For TTRX, the total return equals the price-only return.

Q4Did TTRX beat the S&P 500?

No, Turn Therapeutics Inc. (TTRX) underperformed the S&P 500 by 76.40 percentage points over the past year. TTRX delivered a total return of -45.86%, compared to the S&P 500's 30.54%. This means a passive S&P 500 index fund outperformed TTRX by 76.40pp during this period.

Q5What is TTRX's worst drawdown?

Turn Therapeutics Inc. (TTRX) experienced a maximum drawdown of -70.54% over the past year, declining from its peak on 2025-10-09 to its trough on 2025-11-20. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is TTRX's long-term total return over 10, 20, or 30 years?

Here are Turn Therapeutics Inc. (TTRX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -45.9% (-6.0% CAGR) — $10,000 would have grown to $5,414. Over 20 years: -45.9% total return (-3.0% CAGR) — $10,000 → $5,414. Over 30 years: -45.9% total return (-2.0% CAGR) — $10,000 → $5,414. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.